The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

Share Price Information for Idox Group (IDOX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 64.60
Bid: 63.20
Ask: 64.80
Change: -0.40 (-0.62%)
Spread: 1.60 (2.532%)
Open: 64.60
High: 64.80
Low: 64.60
Prev. Close: 65.00
IDOX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Trading Update & 2016 Prior Year Adjustment

29 Mar 2019 07:00

RNS Number : 4054U
IDOX PLC
29 March 2019
 

Idox plc

("Idox" or "the Group")

Annual General Meeting Trading Update and 2016 Prior Year Adjustment

 

Idox plc (AIM: IDOX), a leading supplier of specialist information management solutions and services, will be holding its Annual General Meeting at 10.30am today. At the meeting, the Chairman will make the following statement:

Trading and Business Update

We are making good progress with our strategy to move the Group to a more stable footing and build shareholder value. The Board remains confident in the prospects for the business and is pleased to confirm that the Group continues to trade in line with market expectations..

We continue to make financial and operational governance improvements and have made good progress across a number of fronts as set out below. As part of this ongoing process we have recently identified 2016 year end contract documentation irregularities that will necessitate a modest adjustment to prior year brought forward balances as set out in the section headed 'Prior year adjustment'.

We are pleased to advise on our progress across the Group in the following areas:

· 'The 4 Pillars' programme. Improving the quality of Revenue, EBITDA, Cashflow together with the simplification of the organisation, including:

o implementing appropriate revenue recognition policies, practices and understanding throughout the organisation to ensure our revenues match our performance obligations;

o establishing visibility over our data and information to understand more fully the financial risks and opportunities throughout our Group; and

o closer integration of previous acquisitions across the business;

· Selling. Reassessing our selling methodologies, improving governance through the appointment of a Chief Process and Transformation officer, implementing sales governance, establishing robust pricing models and stratifying our sales resources to match the profiles of our customer base;

· Product. Investing in product strategy with the appointment of a new Product Director, co-ordinating development activity, and co-ordinating and reviewing existing third-party licensing arrangements;

· Services. Addressing historical challenges of low levels of chargeability for professional services and maximising services revenue opportunities generally;

· Infrastructure. Creating more resilient and cost-effective IT infrastructure that underpins both our Corporate and customer activities. Improving engagement of our back-office activities with wider operational activities;

· Employees. Establishing an employee engagement programme to improve communication and work practices throughout the organisation; and

· KPIs. Identifying and monitoring appropriate KPI's throughout the organisation and challenging existing operating models using those KPIs as a guide.

 

2016 prior year adjustment

As part of our more stringent approach to contract monitoring and execution, we have recently identified a number of irregularities in historic customer contracts, signed and recognised in the year ended 31 October 2016 ("FY16"), that had been inappropriately amended by a small number of employees. The effect of these contract irregularities is that revenue and profit of approximately £4.5 million to £5.5 million was recognised in FY16, the majority of which should have been recognised in later periods. Those employees still with the company have been suspended pending an investigation into their conduct. Having thoroughly assessed the financial impact, the Board has concluded that this issue is historical in nature and will have no impact on the Group's cash balances or its current year financial performance although a small adjustment to the opening net assets will be required, as described below.

Whilst we continue to work through the detail of this issue to understand the full effect on the previously reported FY16 results, the expected Group net assets will be adjusted from the opening balance of £49.8m at 1 November 2018 by approximately £0.75m. We anticipate correcting this historical overstatement by way of a prior year adjustment to the opening 2018 balance sheet in the Interim and Final accounts for the year ending 31 October 2019.

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. 

For further information please contact:

Enquiries:

Idox plc +44 (0) 870 333 7101

Chris Stone, Non-Executive Chairman

David Meaden, Chief Executive

Rob Grubb, Chief Financial Officer

 

N+1 Singer (NOMAD and Broker) +44 (0) 20 7496 3000

Shaun Dobson / Jen Boorer

Tom Salvesen (Corporate Broking)

About Idox plc

For more information see www.idoxplc.com @Idoxgroup

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCDDGDXBSDBGCI
Date   Source Headline
22nd Feb 20213:15 pmGNWForm 8.3 - [IDOX plc - Opening Declaration] - (HHL) - CORRECTION
22nd Feb 20213:11 pmGNWForm 8.3 - [IDOX plc - Opening Declaration] - (CGWL) - CORRECTION
22nd Feb 20212:05 pmRNSForm 8.5 (EPT/RI)
22nd Feb 20211:39 pmRNSForm 8.5 (EPT/RI) - Replacement
22nd Feb 20211:31 pmRNSForm 8.3 - IDOX Plc
22nd Feb 202112:51 pmGNWForm 8.3 - Idox plc
22nd Feb 202112:00 pmRNSForm 8.5 (EPT/RI) IDOX Plc
22nd Feb 202111:58 amGNWForm 8.3 - [IDOX plc - Opening Declaration] - (HHL)
22nd Feb 202111:49 amGNWForm 8.3 - [IDOX plc - Opening Declaration] - (CGWL)
22nd Feb 202110:34 amRNSForm 8.3 - IDOX Plc
22nd Feb 202110:31 amRNSForm 8.5 (EPT/RI)
19th Feb 20215:35 pmRNSForm 8.3 Disclosure
19th Feb 20215:12 pmRNSForm 8.3 - Idox Plc
19th Feb 20213:02 pmRNSForm 8.3 - Idox Plc
19th Feb 20212:45 pmGNWForm 8.3 - Octopus Investments - - IDOX plc
19th Feb 202111:26 amGNWForm 8.3 - Idox Plc
19th Feb 20217:39 amRNSStatement re Possible Offer
19th Feb 20217:00 amRNSStatement re Possible Offer
3rd Feb 20217:00 amRNSAGM Date & Dividend Payment Schedule
2nd Feb 20217:00 amRNSFY20 Results
19th Jan 20214:05 pmRNSExercise of Share Options & Total Voting Rights
19th Jan 20217:00 amRNSNotice of Final Results
2nd Dec 20207:00 amRNSContract Win
2nd Dec 20207:00 amRNSExercise of Share Options and Total Voting Rights
26th Nov 202011:37 amRNSInvestor presentation
17th Nov 20207:00 amRNSYear End Trading Update
27th Oct 20207:00 amRNSExercise of Share Options & Total Voting Rights
22nd Oct 20205:35 pmRNSHolding(s) in Company
21st Oct 20207:00 amRNSAppointment of Head of Professional Services
14th Oct 20205:45 pmRNSReplacement: Exercise of Share Options & TVR
14th Oct 202011:51 amRNSHolding(s) in Company
14th Oct 20207:00 amRNSIdox Rebrand and Recent Progress with Idox Cloud
13th Oct 20207:00 amRNSExercise of Share Options & Total Voting Rights
23rd Sep 20205:30 pmRNSHolding(s) in Company
28th Aug 20207:00 amRNSDirectorate Changes
25th Aug 20207:00 amRNSExercise of Share Options & Total Voting Rights
16th Jul 20207:00 amRNSExercise of Share Options & Total Voting Rights
8th Jul 20201:58 pmRNSHolding(s) in Company
19th Jun 20207:00 amRNSGrant of Options
15th Jun 20207:00 amRNSHalf-year Report
28th May 202011:18 amRNSResult of AGM
19th May 20207:00 amRNSHalf Year Trading Update
1st May 20207:42 amRNSPosting of Annual Report and Notice of AGM
28th Apr 20204:33 pmRNSHolding(s) in Company
20th Apr 20208:01 amRNSProgressive publishes new research
14th Apr 20207:01 amRNSDirectorate Change
14th Apr 20207:00 amRNSFinal Results
30th Mar 20204:36 pmRNSPrice Monitoring Extension
23rd Mar 20207:00 amRNSNotice of Results Update
16th Mar 20207:00 amRNSTrading Update and Notice of Results update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.